Correlation Between Wearable Devices and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both Wearable Devices and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wearable Devices and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wearable Devices and bioAffinity Technologies,, you can compare the effects of market volatilities on Wearable Devices and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wearable Devices with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wearable Devices and BioAffinity Technologies,.
Diversification Opportunities for Wearable Devices and BioAffinity Technologies,
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Wearable and BioAffinity is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Wearable Devices and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Wearable Devices is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wearable Devices are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Wearable Devices i.e., Wearable Devices and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between Wearable Devices and BioAffinity Technologies,
Given the investment horizon of 90 days Wearable Devices is expected to generate 2.24 times more return on investment than BioAffinity Technologies,. However, Wearable Devices is 2.24 times more volatile than bioAffinity Technologies,. It trades about -0.17 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about -0.45 per unit of risk. If you would invest 197.00 in Wearable Devices on October 23, 2024 and sell it today you would lose (62.00) from holding Wearable Devices or give up 31.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Wearable Devices vs. bioAffinity Technologies,
Performance |
| Timeline |
| Wearable Devices |
| bioAffinity Technologies, |
Wearable Devices and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Wearable Devices and BioAffinity Technologies,
The main advantage of trading using opposite Wearable Devices and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wearable Devices position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.| Wearable Devices vs. Koss Corporation | Wearable Devices vs. Wearable Devices | Wearable Devices vs. Sonos Inc | Wearable Devices vs. LG Display Co |
| BioAffinity Technologies, vs. Nuvalent | BioAffinity Technologies, vs. Arcellx | BioAffinity Technologies, vs. Vaxcyte | BioAffinity Technologies, vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |